Skip to main content
Clinical Trials/JPRN-UMIN000009275
JPRN-UMIN000009275
Recruiting
Phase 2

PhaseII study of maintenance S-1 after chemotherapy with platinium+pemetrexed in advanced nonsquamous NSCLC. - PhaseII study of maintenance S-1 after chemotherapy with platinium+pemetrexed in advanced nonsquamous NSCLC.

Kansai Medical University0 sites22 target enrollmentNovember 6, 2012

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
on Squamous Non Small Cell Lung Cancer
Sponsor
Kansai Medical University
Enrollment
22
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 6, 2012
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\)Interstitial pneumonia or pulmonary fibrosis on chest X\-ray 2\) History of serious drug allergy 3\)Patients with active double cancer 4\)Patients with pleural or pericardial effusion ,or ascites 5\)Being treated with flucytosine. 6\) History of serious infection 7\)History of HBs antigen 8\)Patients with significant complications a) Uncontrolled angina pectoris, myocardial infarction, heart failure within 3 months b)Uncontrolled diabetes or hypertension c)Current severe infection, or suspicious of severe infection d) Patients whose participation in the trial is judged to be inappropriate by the attending doctor. (e.g., ileus, bleeding tendency, diarrhea and varicella) 9 )Symptomatic brain metastases 10\)Patients with pregnancy or lactation 11\)patients whom it is judged to have difficulty in participation in study because of psychosis or neurologic disease 12\)Patients whose participation in the trial is judged to be inappropriate by the attending doctor.

Outcomes

Primary Outcomes

Not specified

Similar Trials